Manufacturing, Biologic Drugs

Janssen, MeiraGTx Partner on Eye-Focused Gene Therapy

February 01, 2019

Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases.

Lonza Launches Commercial Supply of Second-Gen Andexxa

January 25, 2019

Full commercial launch of the drug is underway in the United States, with Europe to follow.

G-CON Manufacturing and GE Healthcare Collaborate to Advance Early-Stage Cell Therapy and Viral Vector Manufacturing

January 25, 2019

G-CON will provide a complete cleanroom infrastructure for GE Healthcare’s cell therapy and viral vector production platforms that will simplify early-stage manufacturing efforts.

Using Modified Amino Acids to Simplify Fed-Batch Bioprocessing

January 18, 2019

MilliporeSigma’s use of modified amino acids can simplify the fed-batch process in biomanufacturing.

Sanofi, Biomunex Sign Antibody Licensing Agreement

January 15, 2019

The agreement gives Sanofi access to Biomunex’s proprietary bi- and multi-specific-antibody-generating platform.

Catalent Invests $200 Million in Wisconsin and Indiana Sites

January 14, 2019

The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.

NIIMBL Announces New Projects and Funding for Biopharma Manufacturing

January 11, 2019

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) revealed 22 new projects and funding aimed to advance US biopharmaceutical manufacturing.

AbSci, Sanofi in Manufacturing Partnership

January 11, 2019

The companies will collaborate to improve the manufacturability for two of Sanofi’s biotherapeutics.

Selexis Expands Immuno-Oncology Alliance with Agenus

January 10, 2019

Agenus will leverage Selexis’ SUREtechnology Platform to progress Agenus’ portfolio of next-generation antibody programs.

Fujifilm Invests in Biopharmaceutical Production Capacity

January 10, 2019

Fujifilm increases capacity of its Bio-CDMO business with an expansion of production in North Carolina.